Enhancing the CONSORT initiative: renewal of intellectual support for the CONSORT Group

加强 CONSORT 计划：为 CONSORT 集团提供新的智力支持

• 批准号: MR/J004871/1
• 负责人: Douglas Altman
• 金额: $ 33.65万
• 依托单位: Oxford University Hospitals NHS Trust
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2012
• 资助国家: 英国
• 起止时间: 2012 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=MR%2FJ004871%2F1
• 关键词: Enhancing; CONSORT; initiative; renewal; intellectual

Randomized trials provide the best evidence of the effectiveness (and harms) of health care interventions; they are a crucially important part of the practice of evidence-based medicine. Proper reporting of trials is thus essential to ensure maximum benefit accrues from the trials conducted at great effort and expense. Yet a wealth of evidence shows that reporting of randomized trials is well short of ideal. The CONSORT (Consolidated Standards of Reporting Trials) Statement was developed in 1996 to try to improve the reporting of randomized trials. If randomized trials are not well reported it is difficult for clinicians to use best evidence to inform best practice; patients may not get the best care.The main product of CONSORT Group is the CONSORT Statement, an evidence-based, minimum set of recommendations for reporting randomized trials. In the form of a checklist and flow diagram, CONSORT offers a standard way for authors to prepare reports of trial findings, facilitating their complete and transparent reporting, and aiding their critical appraisal and interpretation. Originally published in 1996, the CONSORT Statement was updated in 2001 and mostly recently in 2010. In addition, several extensions have been developed for specific types of randomized trials. There is now a large and increasing body of evidence that CONSORT has had a beneficial impact on the quality of published articles. CONSORT is used and endorsed of by hundreds of medical journals worldwide. The CONSORT website is viewed nearly a quarter of a million times, annually. It is important that CONSORT is kept up to date to reflect new evidence and changing opinion. In 2005, the CONSORT Group successfully received five year funding from the Health Technology Assessment Research Methodology Programme to support its activities and develop a major update of the recommendations. That funding is coming to the end and we now seek a renewal to enable us to continue to support and enhance the work of the CONSORT Group. We outline four broad, interlinked areas of planned activity relating to the CONSORT Statement and its extensions: to continue to refine and update the guidelines; to continue efforts to improve the implementation of and adherence to CONSORT; to conduct relevant research relating to how randomized trials are reported; and to provide vital infrastructure to support the activities of the CONSORT Group.

随机试验为卫生保健干预措施的有效性(和危害性)提供了最好的证据；它们是循证医学实践中至关重要的部分。因此，适当报告审判情况对于确保以巨大的努力和费用进行的审判获得最大利益至关重要。然而，大量证据表明，对随机试验的报道远远不够理想。CONSORT(报告试验的综合标准)声明于1996年制定，旨在改进随机试验的报告。如果随机试验没有得到很好的报道，临床医生就很难使用最佳证据来提供最佳实践；患者可能得不到最好的护理。CONSORT Group的主要产品是CONSORT声明，这是一套基于证据的、用于报告随机试验的最低建议集。以清单和流程图的形式，CONSORT为作者准备试验结果报告提供了一种标准方式，促进了他们完整和透明的报告，并帮助他们进行批判性评估和解释。最初发布于1996年，康索特声明于2001年更新，最近一次更新是在2010年。此外，还为特定类型的随机试验开发了几个扩展。现在有大量越来越多的证据表明，CONSORT对已发表文章的质量产生了有益的影响。CONSORT被世界各地数百种医学期刊使用和认可。夫妻网站每年的浏览量接近25万次。重要的是，配偶必须保持最新状态，以反映新的证据和不断变化的意见。2005年，联合会小组成功地从卫生技术评估研究方法方案获得了五年资金，以支持其活动并对建议进行重大更新。这笔资金即将结束，我们现在寻求续签，以使我们能够继续支持和加强配偶小组的工作。我们概述了与CONTORT声明及其扩展相关的四个广泛的、相互关联的计划活动领域：继续完善和更新指南；继续努力改进COSORT的实施和遵守；就如何报告随机试验进行相关研究；以及提供重要的基础设施来支持CONSORT小组的活动。

项目成果

Impact of Spin in the Abstracts of Articles Reporting Results of Randomized Controlled Trials in the Field of Cancer: The SPIIN Randomized Controlled Trial

• DOI: 10.1200/jco.2014.56.7503
• 发表时间: 2014-12-20
• 期刊: JOURNAL OF CLINICAL ONCOLOGY
• 影响因子: 45.3
• 作者: Boutron, Isabelle;Altman, Douglas G.;Ravaud, Philippe
• 通讯作者: Ravaud, Philippe